tiprankstipranks
Processa Pharmaceuticals (PCSA)
NASDAQ:PCSA
US Market

Processa Pharmaceuticals (PCSA) Stock Investors

85 Followers
Based on 723,149 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PCSA
On average, investors allocate 0.00% of their portfolios to PCSA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 723,149 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PCSA

1.3%
Last 7
Days
5.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PCSA, out of 723,149 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PCSA Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
1.12%
$2.43
Based on the activity of 13,602 investors who made their portfolios public
The table shows changes in PCSA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PCSA Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.68%
-0.92%
-3.42%
253.91M
Healthcare
DraftKings
7.22%
-0.16%
+1.13%
41.01B
Consumer Cyclical
Assertio Therapeutics
2.70%
-1.25%
-4.65%
98.80M
Healthcare
Micron
5.70%
+11.23%
+26.64%
129.71B
Technology
ChargePoint Holdings
3.94%
-1.55%
-3.54%
723.19M
Consumer Cyclical
Mercadolibre
5.38%
-0.08%
+2.92%
78.58B
Consumer Cyclical
Marathon Digital Holdings
5.68%
-0.85%
+6.82%
5.92B
Financial
Raytheon Technologies
4.09%
-0.66%
-1.15%
127.15B
Industrials
ServiceNow
3.99%
+2.28%
+6.94%
158.80B
Technology
Citigroup
5.12%
>-0.01%
+0.09%
116.50B
Financial
Based on the activity of 723,149 active portfolios
Open your Smart Portfolio

PCSA Investor Analysis

PCSA investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
6.7%
of PCSA holders
are under 35
Average Segment Performance
Average P/E Ratio56.24
Beta7.70
Dividend Yield5.72%
PCSA investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
60.0%
of PCSA holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.68
Beta11.71
Dividend Yield6.34%
PCSA investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
33.3%
of PCSA holders
are over 55
Average Segment Performance
Average P/E Ratio53.31
Beta6.02
Dividend Yield6.03%
Overview of age group and performance of PCSA stock investors
See who invests in PCSA according to age group and performance.

FAQ

How many retail Investors hold PCSA?
<0.1% of TipRanks' retail investors hold PCSA in their portfolios.
    What is PCSA Investor Sentiment?
    PCSA’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of PCSA in the last 7 days?
      ▼ 1.3% of TipRanks' retail investors changed their holding of PCSA in the last 7 days.
        What percentage of retail investors changed their holding of PCSA in the last 30 days?
        ▼ 5.0% of TipRanks' retail investors changed their holding of PCSA in the last 30 days.
          What is the average age of retail investors who hold PCSA?
          The average age of PCSA Holders is between 35–55.
            What other stocks have PCSA investors also bought?
            PCSA Investors also bought CHRS, DKNG, ASRT, MU, CHPT, MELI, MARA, RTX, NOW, C.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ATECAlphatec Holdings
              CORCencora
              NOTVInotiv
              BCRXBioCryst
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis